Laboratory diagnosis of human toxocariasis

Veterinary Parasitology

Volumn 193, Issue 4, 2013, Pages 327-336

  Fillaux, J ^a,b   Magnaval, J F ^c,d  

^a CHU RANGUEIL   (France)

^b UMR 152 IRD Universite Paul Sabatier   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

^d Université Toulouse 3 Paul Sabatier   (France)

Author keywords

Active infection; Diagnostic strategy; Human toxocariasis; Immunodiagnosis

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; HELMINTH ANTIBODY; IMMUNOGLOBULIN G;

ANTIBODY DETECTION; ANTIGEN SPECIFICITY; ARTICLE; CEREBROSPINAL FLUID; CLIMATE; CLINICAL FEATURE; COVERT TOXOCARIASIS; DIAGNOSTIC VALUE; DISEASE TRANSMISSION; HELMINTHIASIS; HUMAN; IMMUNOELECTROPHORESIS; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; INCIDENCE; MOLECULAR DIAGNOSIS; NONHUMAN; PATHOPHYSIOLOGY; PLEOCYTOSIS; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SEROPREVALENCE; SOCIOECONOMICS; SYMPTOMATOLOGY; TAXONOMY; TOXOCARA CANIS; TOXOCARA CATI; TOXOCARIASIS; VISCERAL LARVA MIGRANS SYNDROME; ANIMAL; BLOOD; DIAGNOSTIC PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; FEMALE; IMMUNOLOGY; ISOLATION AND PURIFICATION; LARVA MIGRANS, VISCERAL; PARASITOLOGY; PROCEDURES; TOXOCARA; WESTERN BLOTTING; ZOONOSIS;

BACTERIA (MICROORGANISMS); TOXOCARA; TOXOCARA CANIS; TOXOCARA CATI; VERMES;

ANIMALS; ANTIBODIES, HELMINTH; BLOTTING, WESTERN; CLINICAL LABORATORY TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHILIA; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LARVA MIGRANS, VISCERAL; SENSITIVITY AND SPECIFICITY; TOXOCARA; TOXOCARA CANIS; TOXOCARIASIS; ZOONOSES;

EID: 84875073839     PISSN: 03044017     EISSN: 18732550     Source Type: Journal    
DOI: 10.1016/j.vetpar.2012.12.028     Document Type: Article

References (117)

1. Addiss D.G., Dimock K.A., Eberhard M.L., Lammie P.J. Clinical, parasitologic, and immunologic observations of patients with hydrocele and elephantosis in an area with endemic lymphatic filariasis. J. Infect. Dis. 1995, 171:755-758.
2. Akao N., Ohta N. Toxocariasis in Japan. Parasitol. Int. 2007, 56:87-93.
3. Altcheh J., Nallar M., Conca M., Biancardi M., Freilij H. Toxocariasis: aspectos clinicos y de laboratorio en 54 pacientes. An. Pediatr. (Barc.) 2003, 58:425-431.
4. Balmer A., Munier F. Differential diagnosis of leukocoria and strabismus, first presenting signs of retinoblastoma. Clin. Ophthalmol. 2007, 1:431-439.
5. Barriga O.O. A critical look at the importance, prevalence and control of toxocariasis and the possibilities of immunological control. Vet. Parasitol. 1988, 29:195-234.
6. Bass J.L., Mehta K.A., Glickman L.T., Blocker R., Eppes B.M. Asymptomatic toxocariasis in children: a prospective study and treatment trial. Clin. Pediatr. (Phila.) 1987, 26:441-446.
7. Beaver P.C. Larva migrans. Exp. Parasitol. 1956, 5:587-621.
8. Beaver P.C., Snyder C.H., Carrera G.M., Dent J.H., Lafferty J.W. Chronic eosinophilia due to visceral larva migrans; report of three cases. Pediatrics 1952, 9:7-19.
9. Benitez del Castillo J.M., Herreros G., Guillen J.L., Fenoy S., Banares A., Garcia J. Bilateral ocular toxocariasis demonstrated by aqueous humor enzyme-linked immunosorbent assay. Am. J. Ophthalmol. 1995, 119:514-516.
10. Biguet J., Rose F., Capron A., Tanvanky P. Contribution de l'analyse immunoélectrophorétique à la connaissance des antigènes vermineux. Incidences pratiques sur leur standardisation, leur purification et le diagnostic des helminthiases par immunoélectrophorèse. Rev. Immunol. Ther. Antimicrob. 1965, 29:5-23.
11. Bobic B., Klun I., Vujanic M., Nikolic A., Ivovic V., Zivkovic T., Djurkovic-Djakovic O. Comparative evaluation of three commercial Toxoplasma-specific IgG antibody avidity tests and significance in different clinical settings. J. Med. Microbiol. 2009, 58:358-364.
12. Brunello F., Genchi C., Falagiani P. Detection of larva-specific IgE in human toxocariasis. Trans. R. Soc. Trop. Med. Hyg. 1983, 77:279-280.
13. Buijs J., Borsboom G., Renting M., Hilgersom W.J., van Wieringen J.C., Jansen G., Neijens J. Relationship between allergic manifestations and Toxocara seropositivity: a cross-sectional study among elementary school children. Eur. Respir. J. 1997, 10:1467-1475.
14. Caldera F., Burlone M.E., Genchi C., Pirisi M., Bartoli E. Toxocara encephalitis presenting with autonomous nervous system involvement. Infection 2012, 10.1007/s15010-0121-0342-6.
15. Capron A., Biguet J., Rose F., Vernes A. Les antigenes de Schistosoma mansoni. II. Etude immunoelectrophoretique comparee de divers stades larvaires et des adults des deux sexes. Aspects immunologiques des relations hote-parasite de la cervaire et de l'adulte de S. mansoni. Ann. Inst. Pasteur. (Paris) 1965, 109:798-810.
16. Chaudhuri R.N., Saha T.K. Tropical eosinophilia. Experiments with Toxocara canis. Lancet 1959, 2:493-494.
17. Choi D., Lim J.H., Choi D.C., Paik S.W., Kim S.H., Huh S. Toxocariasis and ingestion of raw cow liver in patients with eosinophilia. Korean J. Parasitol. 2008, 46:139-143.
18. Cilla G., Perez-Trallero E., Gutierrez C., Part C., Gomariz M. Seroprevalence of Toxocara infection in middle-class and disadvantaged children in northern Spain (Gipuzkoa, Basque Country). Eur. J. Epidemiol. 1996, 12:541-543.
19. Courtade H., Recco P., Magnaval J.F., Charlet J.P., Seguela J.P. Etude comparative de 2 tests ELISA Toxocara vis-à-vis du western blot. Bull. Soc. Fr. Parasitol. 1995, 13:37-53.
20. Cypess R.H., Karol M.H., Zidian J.L., Glickman L.T., Gitlin D. Larva-specific antibodies in patients with visceral larva migrans. J. Infect. Dis. 1977, 135:633-640.
21. Daeki A.O., Craig P.S., Shambesh M.K. IgG-subclass antibody responses and the natural history of hepatic cystic echinococcosis in asymptomatic patients. Ann. Trop. Med. Parasitol. 2000, 94:319-328.
22. de Savigny D.H. In vitro maintenance of Toxocara canis larvae and a simple method for the production of Toxocara ES antigen for use in serodiagnostic tests for visceral larva migrans. J. Parasitol. 1975, 61:781-782.
23. de Savigny D.H., Voller A., Woodruff A.W. Toxocariasis: serological diagnosis by enzyme immunoassay. J. Clin. Pathol. 1979, 32:284-288.
24. de Souza E.C., Nakashima Y. Diffuse unilateral subacute neuroretinitis. Report of transvitreal surgical removal of a subretinal nematode. Ophthalmology 1995, 102:1183-1186.
25. Despommier D. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin. Microbiol. Rev. 2003, 16:265-272.
26. de Visser L., Rothova A., de Boer J.H., van Loon A.M., Kerkhoff F.T., Canninga-van Dijk M.R., Weersink A.Y., de Groot-Mijnes J.D. Diagnosis of ocular toxocariasis by establishing intraocular antibody production. Am. J. Ophthalmol. 2008, 145:369-374.
27. Dziemian E., Zarnowska H., Kolodziej-Sobocinska M., Machnicka B. Determination of the relative avidity of the specific IgG antibodies in human toxocariasis. Parasite Immunol. 2008, 30:187-190.
28. Eberhard M.L., Alfano E. Adult Toxocara cati infections in U.S. children: report of four cases. Am. J. Trop. Med. Hyg. 1998, 59:404-406.
29. Eberhardt O., Bialek R., Nagele T., Dichgans J. Eosinophilic meningomyelitis in toxocariasis: case report and review of the literature. Clin. Neurol. Neurosurg. 2005, 107:432-438.
30. Ehrhard T., Kernbaum S. Toxocara canis et toxocarose humaine. Bulletin de l'Institut Pasteur 1979, 77:225-287.
31. Elefant G.R., Shimizu S.H., Sanchez M.C., Jacob C.M., Ferreira A.W. A serological follow-up of toxocariasis patients after chemotherapy based on the detection of IgG, IgA, and IgE antibodies by enzyme-linked immunosorbent assay. J. Clin. Lab. Anal. 2006, 20:164-172.
32. Engvall E., Perlmann P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry 1971, 8:871-874.
33. Esteban J.I., Shih J.W., Tai C.C., Bodner A.J., Kay J.W., Alter H.J. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood. Lancet 1985, 2:1083-1086.
34. Fernando S.T., Vasudevan B., Hamza M.H., Panditha-Gunawardene I.K., Samarasinghe H.T. Precipitin reactions in monkeys (Macaca sinica) experimentally infected with Toxocara canis and in children with visceral larva migrans syndrome. J. Comp. Pathol. 1970, 80:407-414.
35. Fisher M. Toxocara cati: an underestimated zoonotic agent. Trends Parasitol. 2003, 19:167-170.
36. Gavignet B., Piarroux R., Aubin F., Millon L., Humbert P. Cutaneous manifestations of human toxocariasis. J. Am. Acad. Dermatol. 2008, 59:1031-1042.
37. Gems D., Ferguson C.J., Robertson B.D., Nieves R., Page A.P., Blaxter M.L., Maizels R.M. An abundant, trans-spliced mRNA from Toxocara canis infective larvae encodes a 26-kDa protein with homology to phosphatidylethanolamine-binding proteins. J. Biol. Chem. 1995, 270:18517-18522.
38. Genchi C., Tinelli M., Brunello F., Falagiani P. Serodiagnosis of ocular toxocariasis: a comparison of specific IgE and IgG. Trans. R. Soc. Trop. Med. Hyg. 1986, 80:993-994.
39. Gillespie S.H., Bidwell D., Voller A., Robertson B.D., Maizels R.M. Diagnosis of human toxocariasis by antigen capture enzyme linked immunosorbent assay. J. Clin. Pathol. 1993, 46:551-554.
40. Gillespie S.H., Dinning W.J., Voller A., Crowcroft N.S. The spectrum of ocular toxocariasis. Eye (Lond.) 1993, 7(Pt 3):415-418.
41. Glickman L.T., Schantz P.M. Epidemiology and pathogenesis of zoonotic toxocariasis. Epidemiol. Rev. 1981, 3:230-250.
42. Glickman L.T., Schantz P., Dombroske R., Cypess R. Evaluation of serodiagnostic tests for visceral larva migrans. Am. J. Trop. Med. Hyg. 1978, 27:492-498.
43. Glickman L.T., Schantz P.M., Grieve R.B. Toxocariasis. Immunodiagnosis of Parasitic Diseases 1986, 201-231. Academic Press, New-York. K.W. Walls, P.M. Schantz (Eds.).
44. Glickman L.T., Magnaval J.F., Domanski L.M., Shofer F.S., Lauria S.S., Gottstein B., Brochier B. Visceral larva migrans in French adults: a new disease syndrome?. Am. J. Epidemiol. 1987, 125:1019-1034.
45. Gonzalez-Quintela A., Gude F., Campos J., Garea M.T., Romero P.A., Rey J., Meijide L.M., Fernandez-Merino M.C., Vidal C. Toxocara infection seroprevalence and its relationship with atopic features in a general adult population. Int. Arch. Allergy Immunol. 2006, 139:317-324.
46. Good B., Holland C.V., Taylor M.R., Larragy J., Moriarty P., O'Regan M. Ocular toxocariasis in schoolchildren. Clin. Infect. Dis. 2004, 39:173-178.
47. Gueglio B., de Gentile L., Nguyen J.M., Achard J., Chabasse D., Marjolet M. Epidemiologic approach to human toxocariasis in western France. Parasitol. Res. 1994, 80:531-536.
48. Guthmann J.P., Ruiz A., Priotto G., Kiguli J., Bonte L., Legros D. Validity, reliability and ease of use in the field of five rapid tests for the diagnosis of Plasmodium falciparum malaria in Uganda. Trans. R. Soc. Trop. Med. Hyg. 2002, 96:254-257.
49. Harant H. La notion d'impasse en parasitologie. Son incidence dans les éosinophilies tissulaires. Bull. Soc. Pathol. Exot. Filiales 1962, 55:576-588.
50. Hoffmeister B., Glaeser S., Flick H., Pornschlegel S., Suttorp N., Bergmann F. Cerebral toxocariasis after consumption of raw duck liver. Am. J. Trop. Med. Hyg. 2007, 76:600-602.
51. Hogarth-Scott R.S., Johansson S.G., Bennich H. Antibodies to Toxocara in the sera of visceral larva migrans patients: the significance of raised levels of IgE. Clin. Exp. Immunol. 1969, 5:619-625.
52. Ishiwata K., Shinohara A., Yagi K., Horii Y., Tsuchiya K., Nawa Y. Identification of tissue-embedded ascarid larvae by ribosomal DNA sequencing. Parasitol. Res. 2004, 92:50-52.
53. Jacquier P., Gottstein B., Stingelin Y., Eckert J. Immunodiagnosis of toxocariasis in humans: evaluation of a new enzyme-linked immunosorbent assay kit. J. Clin. Microbiol. 1991, 29:1831-1835.
54. Jeanneret J.P. Epidémiologie de la toxocarose dans la région jurassienne 1991, Université de Neufchatel, Neufchatel.
55. Johansson S.G., Mellbin T., Vahlquist B. Immunoglobulin levels in Ethiopian preschool children with special reference to high concentrations of immunoglobulin E (IgND). Lancet 1968, 1:1118-1121.
56. Kagan I.G. Serum-agar double diffusion studies with Ascaris antigens. J. Infect. Dis. 1957, 101:11-19.
57. Kagan I.G. Hemagglutination tests with Ascaris antigens. J. Immunol. 1958, 80:396-399.
58. Kennedy M.W., Maizels R.M., Meghji M., Young L., Qureshi F., Smith H.V. Species-specific and common epitopes on the secreted and surface antigens of Toxocara cati and Toxocara canis infective larvae. Parasite Immunol. 1987, 9:407-420.
59. Kirchner T., Altmann H.W. Parasitenlarven als Ursache umschriebener Leberherde. Morphologie und Differentialdiagnose. Pathologe 1987, 8:31-36.
60. Lachaud L., Calas O., Picot M.C., Albaba S., Bourgeois N., Pratlong F. Value of 2 IgG avidity commercial tests used alone or in association to date toxoplasmosis contamination. Diagn. Microbiol. Infect. Dis. 2009, 64:267-274.
61. Lal R.B., Ottesen E.A. Enhanced diagnostic specificity in human filariasis by IgG4 antibody assessment. J. Infect. Dis. 1988, 158:1034-1037.
62. Lassmann B., Tsigrelis C., Virk A. 33-Year-old woman with marked eosinophilia. Mayo Clin. Proc. 2007, 82:103-106.
63. Li Y., Sleigh A.C., Ross A.G., Li Y., Zhang X., Williams G.M., Yu X., Tanner M., McManus D.P. Human susceptibility to Schistosoma japonicum in China correlates with antibody isotypes to native antigens. Trans. R. Soc. Trop. Med. Hyg. 2001, 95:441-448.
64. Liotet S., Bloch-Michel E., Petithory J.C., Batellier L., Chaumeil C. Biological modifications of the vitreous in intraocular parasitosis: preliminary study. Int. Ophthalmol. 1992, 16:75-80.
65. Lopez Mde L., Martin G., Chamorro Mdel C., Mario Alonso J. Toxocariosis en ninos de una region subtropical. Medicina (B Aires) 2005, 65:226-230.
66. Lynch N.R., Wilkes L.K., Hodgen A.N., Turner K.J. Specificity of Toxocara ELISA in tropical populations. Parasite Immunol. 1988, 10:323-337.
67. Magnaval J.F. Comparative efficacy of diethylcarbamazine and mebendazole for the treatment of human toxocariasis. Parasitology 1995, 110(Pt 5):529-533.
68. Magnaval J.F. Diagnostic des hyperéosinophilies au laboratoire. Feuill. Biol. 2004, 45:25-30.
69. Magnaval J.F., Glickman L.T. Management and treatment options for human toxocariasis. Toxocara. The Enigmatic Parasite 2006, CABI Publishing, Oxfordshire, UK. C. Holland, H.V. Smith (Eds.).
70. Magnaval J.F., Glickman L.T., Grieve R.B., Carriere G., Dubly E. Intérêt de l'immunoélectrophorèse utilisant des extraits d'organes génitaux d'Ascaris suum dans le diagnostic de la toxocarose. Bull. Soc. Pathol. Exot. Filiales 1986, 79:634-641.
71. Magnaval J.F., Fabre R., Maurieres P., Charlet J.P., de Larrard B. Application of the western blotting procedure for the immunodiagnosis of human toxocariasis. Parasitol. Res. 1991, 77:697-702.
72. Magnaval J.F., Fabre R., Maurieres P., Charlet J.P., de Larrard B. Evaluation of an immunoenzymatic assay detecting specific anti-Toxocara immunoglobulin E for diagnosis and posttreatment follow-up of human toxocariasis. J. Clin. Microbiol. 1992, 30:2269-2274.
73. Magnaval J.F., Michault A., Calon N., Charlet J.P. Epidemiology of human toxocariasis in La Reunion. Trans. R. Soc. Trop. Med. Hyg. 1994, 88:531-533.
74. Magnaval J.F., Galindo V., Glickman L.T., Clanet M. Human Toxocara infection of the central nervous system and neurological disorders: a case-control study. Parasitology 1997, 115(Pt 5):537-543.
75. Magnaval J.F., Berry A., Fabre R., Morassin B. Eosinophil cationic protein as a possible marker of active human Toxocara infection. Allergy 2001, 56:1096-1099.
76. Magnaval J.F., Glickman L.T., Dorchies P., Morassin B. Highlights of human toxocariasis. Korean J. Parasitol. 2001, 39:1-11.
77. Magnaval J.F., Malard L., Morassin B., Fabre R. Immunodiagnosis of ocular toxocariasis using Western-blot for the detection of specific anti-Toxocara IgG and CAP for the measurement of specific anti-Toxocara IgE. J. Helminthol. 2002, 76:335-339.
78. Magnaval J.F., Faufingue J.H., Morassin B., Fabre R. Eosinophil cationic protein, specific IgE and IgG4 in human toxocariasis. J. Helminthol. 2006, 80:417-423.
79. Maizels R.M., de Savigny D., Ogilvie B.M. Characterization of surface and excretory-secretory antigens of Toxocara canis infective larvae. Parasite Immunol. 1984, 6:23-37.
80. Marty A.M. Toxocariasis. Pathology of Infectious Diseases 2000, Armed Forces Institute of Pathology, Washington, D.C. W.M. Meyers, R.C. Neafie, A.M. Marty, D.J. Wear (Eds.).
81. Miyazaki I. An Illustrated Book Of Helminthic Zoonoses 1991, International Medical Foundation of Japan, Tokyo.
82. Mohamad S., Azmi N.C., Noordin R. Development and evaluation of a sensitive and specific assay for diagnosis of human toxocariasis by use of three recombinant antigens (TES-26, TES-30USM, and TES-120). J. Clin. Microbiol. 2009, 47:1712-1717.
83. Morales O.L., Lopez M.C., Nicholls R.S., Agudelo C. Identification of Toxocara canis antigens by Western blot in experimentally infected rabbits. Rev. Inst. Med. Trop. Sao Paulo 2002, 44:213-216.
84. Morimatsu Y., Akao N., Akiyoshi H., Kawazu T., Okabe Y., Aizawa H. A familial case of visceral larva migrans after ingestion of raw chicken livers: appearance of specific antibody in bronchoalveolar lavage fluid of the patients. Am. J. Trop. Med. Hyg. 2006, 75:303-306.
85. Nichols R.L. The etiology of visceral larva migrans. I. Diagnostic morphology of infective second-stage Toxocara larvae. J. Parasitol. 1956, 42:349-362.
86. Niel G., Pinon J.M., Couture J., Rosin G., Gentilini M. Aspect immunologique de syndromes hyperéosinophiliques évoquant une Larva migrans viscérale. Bull. Soc. Pathol. Exot. Filiales 1973, 66:324-332.
87. Noordin R., Smith H.V., Mohamad S., Maizels R.M., Fong M.Y. Comparison of IgG-ELISA and IgG4-ELISA for Toxocara serodiagnosis. Acta Trop. 2005, 93:57-62.
88. Norhaida A., Suharni M., Liza Sharmini A.T., Tuda J., Rahmah N. rTES-30USM: cloning via assembly PCR, expression, and evaluation of usefulness in the detection of toxocariasis. Ann. Trop. Med. Parasitol. 2008, 102:151-160.
89. Oliver S.T., Cousland H.V., Smith R.W., Girdwood R.W.A. Antibodyisotype reactivity, isotype specific serodiagnostic and IgE antibody specificity in humans infected with Toxocara canis. Trans. R. Soc. Trop. Med. Hyg. 1986, 80:985.
90. Page A.P., Hamilton A.J., Maizels R.M. Toxocara canis: monoclonal antibodies to carbohydrate epitopes of secreted (TES) antigens localize to different secretion-related structures in infective larvae. Exp. Parasitol. 1992, 75:56-71.
91. Page A.P., Rudin W., Fluri E., Blaxter M.L., Maizels R.M. Toxocara canis: a labile antigenic surface coat overlying the epicuticle of infective larvae. Exp. Parasitol. 1992, 75:72-86.
92. Parsons J.C., Grieve R.B. Effect of egg dosage and host genotype on liver trapping in murine larval toxocariasis. J. Parasitol. 1990, 76:53-58.
93. Petithory J.C., Beddock A. Rôle de Toxocara cati dans le syndrome de larva migrans viscéral. Bull. Soc. Fr. Parasitol. 1997, 199-211.
94. Rai S.K., Uga S., Wu Z., Takahashi Y., Matsumura T. Use of polymerase chain reaction in the diagnosis of toxocariasis: an experimental study. Southeast Asian J. Trop. Med. Public Health 1997, 28:541-544.
95. Reiber H., Felgenhauer K. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin. Chim. Acta 1987, 163:319-328.
96. Robertson B.D., Burkot T.R., Gillespie S.H., Kennedy M.W., Wambai Z., Maizels R.M. Detection of circulating parasite antigen and specific antibody in Toxocara canis infections. Clin. Exp. Immunol. 1988, 74:236-241.
97. Roldan W.H., Espinoza Y.A. Evaluation of an enzyme-linked immunoelectrotransfer blot test for the confirmatory serodiagnosis of human toxocariasis. Mem. Inst. Oswaldo Cruz 2009, 104:411-418.
98. Rytomaa T. Organ distribution and histochemical properties of eosinophil granulocytes in rat. Acta Pathol. Microbiol. Scand. Suppl. 1960, 50(Suppl. 140):1-118.
99. Salem G., Schantz P. Toxocaral visceral larva migrans after ingestion of raw lamb liver. Clin. Infect. Dis. 1992, 15:743-744.
100. Sarimehmetoglu H.O., Burgu A., Aycicek H., Gonenc B., Tanyuksel M., Kara M. Application of western blotting procedure for the immunodiagnosis of visceral larva migrans in mice by using excretory/secretory antigens. Dtsch. Tierarztl. Wochenschr. 2001, 108:390-392.
101. Schantz P.M. Toxocara larva migrans now. Am. J. Trop. Med. Hyg. 1989, 41:21-34.
102. Smith H.V. Antibody reactivity in toxocariasis. Toxocara and Toxocarosis: Clinical, Epidemiological and Molecular Perspectives 1993, Institute of Biology and British Society for Parasitology, London. J. Lewis, R.M. Maizels (Eds.).
103. Smith H.V., Noordin R. Diagnostic limitations and futur trends in the serodiagnosis of human toxocariasis. Toxocara. The Enigmatic Parasite 2006, CABI Publishing, Oxfordshire,UK. C.V. Holland, H.V. Smith (Eds.).
104. Smith H.V., Holland C., Taylor M., Magnaval J.F., Schantz P., Maizels R. How common is human toxocariasis? Towards standardizing our knowledge. Trends Parasitol. 2009, 25:182-188.
105. Sturchler D., Weiss N., Gassner M. Transmission of toxocariasis. J. Infect. Dis. 1990, 162:571.
106. Sugane K., Oshima T. Purification and characterization of excretory and secretory antigen of Toxocara canis larvae. Immunology 1983, 50:113-120.
107. Taira K., Saeed I., Permin A., Kapel C.M. Zoonotic risk of Toxocara canis infection through consumption of pig or poultry viscera. Vet. Parasitol. 2004, 121:115-124.
108. Taylor M.R., Keane C.T., O'Connor P., Mulvihill E., Holland C. The expanded spectrum of toxocaral disease. Lancet 1988, 1:692-695.
109. Teixeira C.R., Chieffi P.P., Lescano S.A., de Melo Silva E.O., Fux B., Cury M.C. Frequency and risk factors for toxocariasis in children from a pediatric outpatient center in southeastern Brazil. Rev. Inst. Med. Trop. Sao Paulo 2006, 48:251-255.
110. Thompson D.E., Bundy D.A., Cooper E.S., Schantz P.M. Epidemiological characteristics of Toxocara canis zoonotic infection of children in a Caribbean community. Bull. World Health Organ. 1986, 64:283-290.
111. Vidal J.E., Sztajnbok J., Seguro A.C. Eosinophilic meningoencephalitis due to Toxocara canis: case report and review of the literature. Am. J. Trop. Med. Hyg. 2003, 69:341-343.
112. Watthanakulpanich D., Smith H.V., Hobbs G., Whalley A.J., Billington D. Application of Toxocara canis excretory-secretory antigens and IgG subclass antibodies (IgG1-4) in serodiagnostic assays of human toxocarosis. Acta Trop. 2008, 106:90-95.
113. WHO, 1979. Report of a WHO Expert Committee with the participation of the FAO. Technical Report Series No. 637. WHO Publishing, Genève.
114. Wilder H.C. Nematode endophthalmitis. Trans. Am. Acad. Ophthalmol. Otolaryngol. 1950, 55:99-109.
115. Yahiro S., Cain G., Butler J.E. Identification, characterization and expression of Toxocara canis nematode polyprotein allergen TBA-1. Parasite Immunol. 1998, 20:351-357.
116. Yamasaki H., Araki K., Lim P.K., Zasmy N., Mak J.W., Taib R., Aoki T. Development of a highly specific recombinant Toxocara canis second-stage larva excretory-secretory antigen for immunodiagnosis of human toxocariasis. J. Clin. Microbiol. 2000, 38:1409-1413.
117. Zarnowska H., Jastrzebska M. Excretory-secretory larval antigens of Toxocara canis: physico-chemical characteristics and specificity assayed by Western blot technique. Acta Parasitol. 1994, 39:41-45.